Ahmad Alrawi | SVP Corporate Strategy
Commense Bio

Ahmad Alrawi is a biopharmaceutical professional with roughly 20 years of experience. He has worked at large-cap pharma (Roche), mid-size biotech (Genentech), and startups (Alexion and RaPharma). Ahmad brings US and global expertise in new product development, commercial operations, business development, corporate strategy, diagnostics, market insights, positioning, launch readiness, marketing, and sales. Having served patients in multiple therapeutic areas including rare disease, he is passionate about advancing therapeutic solutions for people with high unmet need through cross-functional collaboration. Ahmad earned his Doctorate of Pharmacy (PharmD) and his Psychology degree from the University of Michigan.

Appearances:

Day 1- World Orphan Drug Congress USA 2025 @ 11:45

Fireside chat: Challenges and approaches for patient identification in Rare Diseases

Patient identification in rare diseases is critical to drug development, commercialization and optimizing patient care and outcomes. Patient identification often hits roadblocks after exhausting the initial wave of diagnosed and engaged individuals, leaving many potential patients underserved. To truly maximize the impact of innovative treatments and the power of integrated care, it’s critical to understand how patients navigate the complexities of the healthcare system and identify gaps in care. In this session, we’ll explore the unique challenges of patient identification and management in rare diseases, while sharing practical, actionable strategies to drive better outcomes. Join us for an engaging and interactive discussion!

Fabiana Marzabal, Sr Director Forecasting, Analytics and Insights, Viridian Therapeutics